Hemorrhagic herpes zoster with contralateral multidermatomal distribution associated with rivaroxaban: An unusual presentation
Autor: | Josiah Sowell, John G. Sowell, H. Harris Reynolds |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Vesicular eruption hemorrhagic herpes zoster viruses apixaban factor Xa inhibitors Case Report Dermatology Virus herpes zoster bilateralis dermatome Dermatomal lcsh:Dermatology Medicine Distribution (pharmacology) rivaroxaban concomitant multidermatomal herpes zoster clopidogrel Rivaroxaban integumentary system business.industry anticoagulant virus diseases lcsh:RL1-803 immunocompetent Ganglion medicine.anatomical_structure purpuric herpes zoster Dermatome Presentation (obstetrics) business medicine.drug |
Zdroj: | JAAD Case Reports, Vol 9, Iss, Pp 31-33 (2021) JAAD Case Reports |
ISSN: | 2352-5126 |
Popis: | Herpes zoster is an infection that develops when varicella-zoster virus reactivates from its latent state in a nerve ganglion. Symptoms typically begin with pain along the affected dermatome, followed within 2-3 days by a vesicular eruption, which is usually diagnostic. Herpes zoster eruption involving 2 disparate dermatomes on different sides of the body is referred to as herpes zoster duplex bilateralis, with a reported occurrence rate of < 0.5% when compared with general herpes zoster.1 Multidermatomal herpes zoster has been most commonly reported in immunocompromised individuals. In a comprehensive literature review by Vu. et al conducted between 1969 and 1999, 6 cases of multidermatomal herpes zoster were reported, with only one of these 6 cases presenting in an immunocompetent adult.2,3 Atypical herpes zoster has been reported in the immunocompetent elderly, suggesting a general immunocompromised state of advanced age with no evident underlying immunocompromised condition.4 The classic clinical presentation consists of clear vesicles in a dermatomal distribution; however, a hemorrhagic or purpuric presentation has been reported in association with anticoagulants, in particular clopidogrel.5 |
Databáze: | OpenAIRE |
Externí odkaz: |